Le Lézard
Classified in: Health
Subject: TDS

Eating disorders symposium a groundbreaking success


PEKIN, Ill., May 2, 2024 /PRNewswire/ -- The International Association of Eating Disorder Professionals (iaedptm) 2024 Symposium marked a significant milestone, reflecting growth and renewed commitment within the field of eating disorder treatment. The event showcased an impressive array of keynotes and sessions, with over 500 attendees from the United States and around the world, half of whom were first-time participants. This surge in new attendees underscores the expanding interest and dedication to advancing treatment.

"We are thrilled with the turnout and the exchange of ideas and research at this year's symposium," said Bonnie Harken, managing director of iaedp. "Seeing so many new faces alongside our seasoned professionals speaks volumes about the progress and the bright future of our field."

The symposium featured a lineup of keynote speakers who are leading experts in psychology, nutritional science, and therapeutic practices related to eating disorders. Their presentations addressed cutting-edge research, innovative treatment approaches, and collaborative care models, receiving praise from attendees for their informative and inspirational content.

Sessions were fully booked throughout the symposium, with topics ranging from the latest clinical interventions to holistic treatment approaches and a Spanish track that served to bridge and support our collective efforts. The event also provided networking opportunities and an environment where professionals could share insights and foster partnerships.

As iaedp continues to grow, it remains dedicated to improving the quality of care provided to those affected by eating disorders through professional education and practical training.

"We are already looking forward to next year's symposium in Palm Desert on February 20-23, 2024, and building on the success of this event," added Harken. "Our goal is to keep the momentum going, pushing the boundaries of what we can achieve together."

For more information about the iaedp's future events, please visit www.iaedpfoundation.com.

The iaedptm Foundation, since 1985, has provided education and training standards to an international and multidisciplinary group of various healthcare treatment providers and helping professions. The iaedp Foundation's President's Council, which provides organization support, includes Alsana Eating Disorder Treatment & Recovery Centers; Banyan; Center for Change; Center for Discovery; Eating Recovery Center; Clear Step; Koru Spring Center; Laureate Eating Disorders Program; The Meadows Ranch; Mind Over Body; Monte Nido & Affiliates; Montecatini; Odyssey Eating Disorder Network; Rogers Behavioral Health; The Renfrew Center; Timberline Knolls Residential Treatment Center; Within Health; and WD Recovery and Wellness Center.

SOURCE iaedp Foundation


These press releases may also interest you

at 02:00
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...

at 01:54
FIRST QUARTER (JANUARY - MARCH 2024) Oder intake SEK 238.5 M (206.6)Net sales SEK 257.2 M (230.2)Operating profit SEK 45.8 M (23.7)Profit after tax SEK 36.7 M (17.6)Earnings per share before/after dilution SEK 1.07 (0.51)Cash flow SEK 87.9 M...

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...



News published on and distributed by: